Trajectory analyses in alcohol treatment research

Area of Science:

• Clinical Psychology
• Psychopharmacology
• Biostatistics

Background:

• Traditional statistical methods in alcohol treatment studies have limitations in capturing nonlinear temporal trends.
• Trajectory analyses offer a more nuanced understanding of treatment effects over time.
• Identifying optimal trial durations and grace periods is crucial for effective alcohol pharmacotherapy.

Purpose of the Study:

• To propose and evaluate flexible smoothing mixed-effects models for characterizing temporal drinking patterns in alcohol treatment.
• To explore the efficacy of topiramate and pharmacotherapies (acamprosate, naltrexone) in reducing alcohol consumption.

Main Methods:

• Employed flexible smoothing mixed-effects models to analyze drinking data from two distinct studies.
• Estimated treatment trajectories for arms including topiramate, placebo, acamprosate, naltrexone, and behavioral interventions.
• Utilized data from a multisite topiramate study and the Combined Pharmacotherapies and Behavioral Interventions study.

Main Results:

• Both topiramate and placebo arms showed declining drinking over the trial, with a faster decline in the topiramate arm.
• Significant differences in heavy drinking probabilities between topiramate and placebo emerged as early as week 2.
• Naltrexone demonstrated superior drinking reduction compared to placebo, though not significantly different when combined with behavioral interventions.

Conclusions:

• Estimated trajectory plots clearly illustrated nonlinear temporal trends in drinking outcomes across different medication treatments.
• The trajectory analysis approach provides a more detailed interpretation of results in pharmacotherapy trials for alcoholism.
• This method is proposed as a valid exploratory tool for evaluating treatment efficacy in clinical trials for alcohol use disorder.